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A B S T R A C T
Because depression is a major source of the global burden of illness-related disability, developing eﬀective
strategies for reducing its incidence is an important public health priority, especially in low-income countries,
where resources for treating depression are scarce. We describe in this report an intervention development
project, funded by the US National Institute of Mental Health, to address “indicated” prevention of depression in
older adults attending rural and urban primary care clinics in Goa, India. Speciﬁcally, participants in the “DIL”
(“Depression in Later Life”) trial were older adults living with mild, subsyndromal symptoms of depression and
anxiety and thus at substantial risk for transitioning to fully syndromal major depression and anxiety disorders.
Building upon the MANAS treatment trial (“Promoting Mental Health”) led by Patel et al. in the same locale, we
present here lessons learned in the development and implementation of a protocol utilizing lay health
counsellors (LHCs) who deliver a multi-component depression prevention intervention organized conceptually
around Problem Solving Therapy for Primary Care (PST), with additional components addressing brief
behavioural treatment of sleep disturbances such as insomnia, meeting basic social casework needs, and
education in self-management of prevalent comorbid chronic diseases, such as diabetes mellitus. To our
knowledge, DIL is the ﬁrst randomized clinical trial addressing the prevention of depressive disorders ever
conducted in a low- or middle-income country.
1. Introduction
Depression in older adults is a growing public health problem in
Low and Middle Income Countries (LMICs), as a result of demographic
transitions [13]. Studies have shown that, in the absence of treatment
options, prevention of depression could prove to be an important
strategy [3,13,14]. In developing such an intervention, previous
research [3,19] indicates that acceptability, feasibility and cost reduc-
tion have to be factored into depression prevention models. Evidence
[8,11,14]shows that older adults are known to suﬀer from substantial
depressive symptomatology without meeting diagnostic criteria for
syndromal major depression. There are several studies [4] [22,23] on
prevention of depression in later life conducted in developed countries
but none from Low and Middle Income countries (LMICs). Hence, there
is a need to develop a scalable intervention that targets older adults
with subthreshold depression, with an aim to prevent the onset of
depressive disorders in later life [10,14,20].
Progress in research [8,14,23] among older adults has yielded an
accumulation of knowledge on how to identify those individuals with
the highest risk of developing a mental disorder, together with several
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preventive interventions in randomized controlled trials [4,11] show-
ing that (indicated) prevention may be possible and eﬀective in older
adults. One such study was the MANAS (“Promoting Mental Health”)
cluster-randomized trial by Patel et al. [11], which showed a relative
risk reduction at 6 months of 50% in the incidence of ICD-10 conﬁrmed
depression and anxiety disorders in a mixed-age sample of those
receiving a collaborative stepped care (12.7%) versus those receiving
enhance usual care (25%). We hypothesised that the MANAS interven-
tion, modiﬁed to add other evidence-based components [1,11]and
delivered by lay health counsellors (LHCs), is not just a treatment
intervention but a preventive intervention as well.
Indicated prevention [1,3,13,20,23]is aimed at individuals who
have sub-threshold depression (i.e. some symptoms of a depressive
disorder) but do not meet diagnostic criteria for a depressive disorder.
Indicated prevention has two objectives; one to reduce the symptoms of
emotional distress that place persons at risk for common mental
disorders like depression and anxiety, thereby increasing the quality
of life; and secondly, to strengthen protective factors in order to prevent
the onset of major depression disorder and other common mental
disorders, such as anxiety disorders.
In this study, we aimed to extend the incidental prevention results of
the MANAS study [11] into a speciﬁc hypothesis-driven study. The
MANAS study documented a trend worthy reduction in the incidence of
depressive and anxiety disorders at six months, incidental to the
primary treatment results for prevalent cases. The speciﬁc focus on
older adults in Goa reﬂects both their growing numbers in Goa and the
high exposure to risk factors for late-life depression. This was the ﬁrst
trial aimed at prevention of depression in older people living in a low or
middle income country, using lay health counsellors (LHCs) and
exploring a combination of approaches. The primary approach applied
in this study is problem-solving therapy as developed for use in primary
care settings (PST).
PST is a brief, focused, and scalable psychological intervention
[7,14] that has been used with a variety of patients in primary care
settings, including people with depression, chronic illness, and suicidal
thoughts and behaviours. In essence, PST is a learning-based psy-
chotherapy that has elements of behavioural activation, aims to
improve active coping, and enhances a sense of self-eﬃcacy. While
other structured, depression-speciﬁc psychotherapies (e.g., cognitive
behavioural therapy and interpersonal psychotherapy) have been
shown to prevent major depression in indicated prevention trials, PST
is briefer and simpler than CBT or IPT and can be delivered by
personnel without extensive training in mental health.
1.1. Objectives
The Depression in Late life (“DIL”) trial was funded by the US
National Institute of Mental Health through an intervention develop-
ment grant (R34 MH96997) and a center grant (P30 MH90333). (“DIL”
also means “heart” in the local Konkani language.) The trial was
registered with the ClinicalTrials.gov (NCT02145429). The objectives
of the study were twofold: 1) to develop a scalable intervention (DIL,
“Depression in Later Life”), using risk reduction strategies aimed at
prevention of depression and frequently co-occurring anxiety disorders
by targeting persons with sub-threshold depression; and, 2) to test the
feasibility and acceptability of delivering the intervention with LHCs,
who had been used to deliver treatment for people with dementia,
schizophrenia, and common mental disorders (depression and anxiety)
in this region in various other studies [11,12,17]. The DIL intervention
as developed in the formative work described here integrated evidence-
based components: (1) Problem Solving Therapy (PST) and Brief
Behavioural Therapy for Insomnia (BBTI) as reported in a previous
review [1,13] (2) locally relevant social casework, such as facilitating
access to senior citizen programs from the Government of Goa and (3)
education in self-management of medical comorbidities frequent in
depression, including diabetes mellitus, hypertension, arthritis and
other chronic ailments, based on the formative work by Cohen et al.
[2].
We used a pilot randomized controlled trial design to: 1) gather data
on the feasibility and acceptability of identifying, enrolling, randomiz-
ing and retaining participants; 2) implement the experimental inter-
vention and, as a comparator condition, enhanced usual care; 3)
identify barriers to study conduct and develop strategies for addressing
them; and 4) assess the ﬁdelity of the DIL implementation. We collected
measures of feasibility, acceptability, tolerability, and safety and
gathered information to estimate an eﬀect size in the reduction of
symptoms of emotional distress and in the incidence of common mental
disorders (depression and anxiety).
2. Material and methods
2.1. Setting
The study was conducted in Goa, the smallest state in India, with a
population of 1.3 million [2,11]. Goa has a greater proportion of older
adults, and age-related medical and social conditions have become
more relevant in this region. Thirty eight percent of the population live
in rural areas, and 66% are Hindus. Agriculture and tourism are the
main sources of income. We conducted the study at two health centres
under the jurisdiction of the Department of Preventive and Social
Medicine at the Goa Medical College, the Urban Health Center, St Cruz
and Rural Health Center, Mandur and the surrounding communities
served by these centers. The urban health center serves a population of
around 12,000 while the Rural Health Center caters to a population of
42,000. The participants were recruited by screening those visiting the
health centers, as well as from the community in both the rural and
urban regions.
2.2. Study design
We conducted a randomized controlled trial with parallel arms and
with equal allocation of participants in each arm. The study was a trial
of “indicated” prevention, enrolling persons with sub-threshold depres-
sion/anxiety symptoms and thus at high risk for transitioning into fully
syndromal common mental disorders, such as major depression and
frequently co-occurring anxiety disorders, e.g., generalized anxiety
disorder.
2.3. Randomization
Randomization was carried out after baseline assessment and
consent to participate. The project statistician (SJA) randomly assigned
participants to either Enhanced Usual Care [EUC] (Treatment A) or DIL
Problem-Solving Treatment [DIL-PST] (Treatment B), using a rando-
mized block scheme. The sample was stratiﬁed for urban/rural status,
sex, and the site of recruitment (community/health facility). The
criteria for stratiﬁcation were selected by the Trial Steering
Committee based upon the possible impact of each stratiﬁcation
variable on the ﬁnal outcome. Random blocks of size 8 were used to
ensure equal distribution in the two arms at shorter intervals. All study
personnel were masked to random assignment.
2.4. Instruments
The instruments (see Table 1) used for the study were chosen to
measure sub-threshold depression and disability and to rule out
prevalent cases of cognitive impairment (dementia), depression and
anxiety. These instruments had been used in the region in previous
studies. Data collection was done using hand-held tablet devises
programmed with the Sangath digital Tool for Advanced Research
(STAR) [15] software. Electronic data capturing improved eﬃciency
and minimised missing data.
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3. Participants and procedures
3.1. Inclusion criteria
To be eligible for the study, a potential participant had to be aged 60
or older. S/he needed to score 4 or more on the General Health
Questionnaire, considered to be an indication of increased depressive
and anxiety symptomatology. We arrived at the cutoﬀ based on our
formative work and in consultation with experts in the Trial Steering
Committee. Participants had to speak Konkani, Hindi or English and
were expected to reside in the same area for the next 12 months (the
duration of follow up in the study).
3.2. Exclusion criteria
We excluded those with a current depressive or anxiety disorder, as
determined by the MINI 6.0, moderate/high suicide risk, i.e., intent or
plan to attempt suicide in the near future, history of psychiatric
disorders other than non-psychotic unipolar major depression or
anxiety disorder, those with low cognitive scores (HMMSE score below
24), patients taking antidepressants, or those with acute or severe
medical illness. Our intention was to enroll participants at high risk for
a common mental disorder but without a history of current mental
illness that would indicate treatment. Approximately 20–25% of older
adults with subthreshold symptoms are expected to transition to an
episode of frank clinical depression [8,13,14]or anxiety disorder within
1–2 years, while another third will continue to live with chronic mild
symptoms which can be disabling in their own right.
3.3. Sample size and power calculations
We initially set out to recruit a sample of 120 participants (60 per
arm), but as the trial progressed with a faster rate of enrollment than
originally anticipated, we increased the sample size to 180 (90 per arm)
after consultation with NIMH program staﬀ and with the members of
our Data Safety Monitoring Board. Assuming that α is set to 0.05, with
two-sided tests, then with sample sizes of 60 per group, we could detect,
with 81% power, a standardized (pre-post) mean diﬀerence of depres-
sion measures (GHQ 12 score) between intervention groups to 0.52 sd,
which is typically considered to be a medium to large eﬀect size.
Increasing to 90 patients per group allows detection of a more modest
mean diﬀerence of 0.42 sd, – a more likely eﬀect. If the N's were kept
the same (60/group), the power to detect the same 0.42 sd mean
diﬀerence would be less than 63%.
Therefore, we revised our sample “n” upward to 180 people aged 60
or older. Recruitment took 12 months (an average intake of about 15
participants monthly or 3–4 per week). As a pilot study, the randomized
prevention trial focused primarily on feasibility, retention, and accept-
ability, and preliminary estimates of eﬃcacy. We deﬁned recruitment
feasibility as meeting 100% of targeted randomization (n = 180), with
20% or less of eligible subjects refusing randomization. We were able to
demonstrate feasibility of enrollment and retention. Our proposed
approaches to inferential data analysis are speciﬁed below.
3.4. Screening: identiﬁcation and recruitment procedure
Trained research assistants interviewed all those aged 60 and older
attending the rural and urban health centres. Recruitment was extended
to the sub-centers under the rural health center and directly from the
community in order to achieve the targeted enrollment. Research staﬀ
visited every house in a given locality to identify participants eligible
for the trial during community screening. The researchers used the
standardised General Health Questionnaire (GHQ) to evaluate depres-
sive and anxiety symptoms of respondents. Those who scored 4 or more
in the GHQ scale were deemed to have symptoms of depression and
anxiety placing them at risk for episodes of mental illness. However,
potential participants were further screened using a diagnostic tool, the
Mini International Neuropsychiatric Interview (MINI) 6.0, to rule out
active cases of depression or anxiety disorders. Hence only those
participants who were negative on the MINI 6.0 and scored 4 or more
on the GHQ were eligible. To assess the cognitive ability of the
participants, we administered the standardised Hindi Mini Mental
State Examination (HMMSE). Those who scored 24 or more were
included in the study. As a secondary outcome, we assessed the
participant's disability rating using the WHO Disability Assessment
Schedule. Informed consent was sought from those participants deemed
eligible for the study. The informed consent process was audio recorded
to assess ﬁdelity.
3.5. Baseline assessment
The assessment included collection of demographic data, e.g., age,
gender, marital status, educational qualiﬁcation, and occupation. In
addition, we collected data on the number of persons in the household,
including children and/or grandchildren, and on self-reported chronic
diseases for which participants were currently receiving care, including
Table 1
DIL assessment instruments.
Instrument Description Outcome Contextual validity
GHQ 12-item questionnaire screening tool for identifying non-psychotic
and minor psychiatric disorders. Designed to capture depression and
anxiety.
Prevalence of moderate to severe
non-psychotic disorders; mean
total score
Validated for international use and used in previous
trials6,18 in Goa
MINI 6.019 Brief structured interview for the major Axis I psychiatric disorders
in DSM-IV and ICD-10 and is divided into modules. Major
depressive episode, panic disorder, alcohol abuse/dependence,
substance abuse/dependence and generalized anxiety disorder are
the modules used in this study
Presence of Axis I psychiatric
disorders
Validated for international use and used in previous
trials in Goa
WHODAS20 12-item questionnaire for measuring functional impairment over the
previous 30 days. In addition, two items assess number of days the
person was unable to work in the previous 30 days
Total disability score; quality
adjusted life years; number of
days out of work
Validated for international use and used in previous
trials in Goa
HMMSE 22 items questionnaire which test diﬀerent components of
intellectual capability. The items cover several areas of cognitive
functioning such as orientation to time and place, memory,
attention and concentration, recognition of objects, language
function, both comprehension and expressive speech, motor
functioning and praxis
Total cognitive score Adapted Hindi version validated for use in illiterate
Hindi speaking population. Hindi adapted version
has been translated to Konkani.
PHQ-9 (item-9) Nine-item questionnaire assessment of depressive symptoms on
scale of 0–3. (Only item 9 pertaining to suicidal behaviour is used in
this study) since the GHQ did not have this item.
Prevalence of suicide risk Validated in primary care and Konkani version
validated in Goa [6,9,11]
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diabetes mellitus and hypertension. Current medication history was
sought before administering the GHQ scale. Medication use, with a
particular focus on psychotropic drug use, was ascertained via exam-
ination of hospital records and prescriptions, and not merely by self-
report of respondents. We also collected the cognitive scores of the
participants using the Hindi Mini Mental State Examination (HMMSE)
tool and the disability rating using the WHO Disability Assessment
Schedule.
3.6. Summary of trial accrual
We approached 807 persons at the recruitment centres (primary
healthcare clinics and the community) (DIL consort diagram shown in
Fig. 1). Of these, 797 were eligible for the screening; after consent
refusal, a total of 640 persons were screened for trial eligibility. 577
persons completed the screening, of whom 219 were eligible for the
study. The primary reason for non-eligibility was failure to meet the
criterion for sub threshold depression (i.e. a GHQ score below 4). This
was seen in 274 persons and accounted for 76.8% of persons deemed
ineligible. The other notable reason for ineligibility was low cognitive
ability, as assessed using HMMSE. Cognitive impairment accounted for
44 (12.3%) of the exclusions.
Of the 219 eligible persons, 38 (17.4%) did not consent to the study,
leaving 181 (82.6%) participants enrolled in the study. Of the 181
participants 67 (37.0%) were male and 114 (63.0%) were female.
Gender was equally distributed in the two study arms.
In summary, of the 640 persons screened for DIL trial eligibility, we
enrolled 181 (28.3%), representing a substantial proportion of primary-
care and community-resident older adults endorsing subthreshold
symptoms of emotional distress, depression and/or anxiety.
Baseline socio-demographic and clinical data are presented in
Table 1. The mean age of participants at baseline was 69.6 (SD 7.2),
and the mean GHQ was 6.3 (SD 1.9).
3.7. DIL intervention
3.7.1. DIL problem solving therapy
As we developed the DIL intervention in our formative work, it
evolved into three components. First, the main theoretical framework
of the DIL intervention was provided by Problem-Solving Therapy
Fig. 1. DIL Master Consort Chart Denise, please DROP this ﬁgure.
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(PST). Thus, trial participants randomized to the experimental arm
were taught the original seven steps of PST, abbreviated into the
acronym INSPIRE. We developed an acronym to simplify the steps of
PST for use by the lay health counsellors who delivered the interven-
tion:
Identify the problem
Note down a realistic achievable goal
Search for possible solutions
Probe through the pros and cons of each solution
Identify a preferred solution(s)
Run with it (action plan)
Evaluate the outcome
However, during the initial formative phase of DIL, we learned that
the participants were unable to remember these seven steps, and thus
we further simpliﬁed PST to a three stage process called Problem-
Solution-Action. We developed a local acronym for these three steps,
called “SAUD,” which means ‘health’ in Konkani. Within these three
components, all seven steps of INSPIRE were taught and practiced
during the session and reinforced during subsequent booster sessions.
Altogether, face to face time with the lay health counsellor totalled
6–7 h over the course of one year, thus constituting a relatively brief
and focused behavioural intervention.
The second component of intervention was social casework. DIL
counsellors were provided with all the relevant information and forms
for the latest revision of the social resources made available for senior
citizens by the Government of Goa. The focus on social case work
originated during the formative phase, in which we learned that people
in this region are often worried about issues of security, including
ﬁnances, food and personal care. Thus the majority of participants
needed help in navigating to available resources.
The third component of the DIL intervention addressed education
and self-management of common medical illnesses. The most common
source of anxiety and worry (“tension” in the local Konkani language)
for the elderly population related to the burden of chronic disease, such
as diabetes, hypertension, and painful osteoarthritis. As part of this
component, lay health counsellors were trained in basic information
regarding common medical disorders among older adults. They were
trained to educate participants about the nature of these disorders and
basic non pharmacological self-management. For chronic pain, coun-
sellors demonstrated suitable, gentle exercises during the session.
The formative phase of the DIL intervention also taught us that
participants were ﬁnding it diﬃcult to follow an intervention which
primarily involved verbal counselling. We therefore developed pictorial
ﬂip charts to aid the counsellor in engaging participants, especially
those with no or very limited literacy. DIL ﬂip charts contained large
images for elders to relate to and understand, while the counsellors had
images and text to ensure ﬁdelity to the theory of the intervention.
Because poor sleep is a risk factor for developing depressive and
anxiety disorders, we believe that improving sleep quality represents an
opportunity for prevention [1,13]. A special strategy to overcome sleep
problems such as insomnia was taught to participants. Based upon our
previous work in older adults attending primary care in the U.S., we
used strategies from Brief Behavioural Therapy for Insomnia (BBTI),
shown to reduce depressive and anxiety symptoms and to improve the
quality of sleep [1]. DIL lay health counsellors provided participants
with basic sleep hygiene information and taught them to monitor their
sleep and wake patterns. A simple sleep monitoring chart was used for
this purpose, requiring the elders to put a tick mark on the chart. A
similar chart was used to monitor their action plan and to motivate the
elders to be proactive. Clinically, we have observed a useful synergy
between improved sleep and more eﬃcient cognitive functioning
required by PST strategies.
3.8. Intervention delivery
The DIL intervention was delivered by lay health counsellors (LHCs)
who are members of the local community, above 30 years of age, and
bachelor's level graduates from any non-health related ﬁeld (including
counselling). We determined desirable characteristics of the LHC based
on the ﬁndings from our initial qualitative study with the older
participants, who deﬁned characteristics of the LHC, with whom they
would be comfortable to interact. The use of LHC's addresses the
shortage of specialty mental health workers and, hence, the need to
task-share and task-shift simple behavioural intervention delivery to
less highly skilled persons. The eﬀectiveness of LHCs in treating
prevalent cases of common mental disorders has been demonstrated
by Patel et al. [11]. The DIL study now represents an extension of LHC-
based intervention models into the realm of prevention. LHC's lacked
any prior training in professional mental health but had some experi-
ence either living with or working with the elderly. LHCs were recruited
by placing advertisements in local newspapers and through word of
mouth. Candidates were screened using a structured interview with the
site principal investigator, project coordinator, and intervention super-
visors, during which they were asked to role play one basic aspect of the
DIL intervention which was sent to them 24 h before the interview via
email. The selected candidates underwent a one-week training which
covered all the aspects of the DIL intervention, including practice
caseloads on non-eligible participants. On completion of the training,
LHC's underwent competency assessments comprised of highly struc-
tured role plays. The counsellors who met the minimum requirement of
80% on the competency assessment progressed to the pilot study. To
assess competency, we used the Therapy Quality Assessment Scale
(TQS). This tool has been utilised in other studies [17,18]in the region.
Counsellors who failed to attain the minimum requirement received
additional training and practise caseload of non-eligible participants
until they achieved required standards of intervention delivery.
3.9. Supervision
Supervision, an important component of LHC-led interventions, was
carried out on a weekly basis with one or both local supervisors present
at every group meeting. The local psychological intervention specialists
were trained by international experts (Jennifer Morse, Ph.D., Assistant
Professor, Counselling Psychology (MSCP), Chatham University and,
Charles F Reynolds III, UPMC Endowed Professor in Geriatric
Psychiatry at the University of Pittsburgh) in PST and BBTI, and they
continued to be supervised by one international specialist via Skype
every fortnight. Supervision included assessment of the quality of the
sessions, using the Therapy Quality Assessment Scale (TQS), based on
selected audio-recordings of the sessions followed by a round of peer-
led feedback. The LHCs discussed their diﬃcult cases with their peers
and local supervisors during group supervision meetings. If interven-
tion-related issues were not addressed by the peer group and local
supervisors, then they discussed the same cases with the international
experts via fortnightly Skype meetings.
3.10. Enhanced usual care
The control group received Enhanced Usual Care (EUC). The results
of repeated assessments of mood and anxiety among participants
randomly assigned to EUC were made known to participants. If the
participant was found to have developed a depressive disorder or an
anxiety disorder, then we notiﬁed their physicians. In addition, we
shared a copy of the DIL manual with physicians caring for participants
randomly assigned to care as usual. In this sense, care as usual was
enhanced by the forwarding of assessments to physicians and patients,
to allow them to act as they deemed appropriate. While enhancing care
as usual in this fashion may make it more challenging to demonstrate
meaningful diﬀerences between the intervention and control arms of
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DIL, we believed it to be ethically necessary to share such clinically
actionable information—a view shared by NIH reviewers and by our
Data Safety Monitoring Board (DSMB).
3.11. Minimizing contamination
Contamination of the Enhanced Usual Care arm was reduced by
masking the clinic doctor to the allocation status. Moreover, the clinic
staﬀs were not conversant with the DIL intervention.
3.12. Outcome evaluation
Outcome evaluation was done at 3, 6 and 12 months after
enrolment. We used the same set of measures as during the baseline
assessment. The primary outcome of the study was to evaluate changes
in symptom burden as reﬂected in GHQ scores. This focus is consistent
with a model of “indicated” depression/anxiety prevention, which
addresses the reduction of symptoms that constitute risk for transition
to clinical episodes of depression and anxiety disorders. We also
collected data on the incidence of episodes of depressive and anxiety
disorders, WHODAS scores and the HMMSE scores as secondary
outcomes. The schedule of assessments and interventions is depicted
in Table 2.
3.13. Fidelity assessments
The ﬁdelity of the DIL intervention was assessed with the following
indicators:
Number and duration of sessions delivered, using Information was
collated from the Counsellor's Session Record which recorded basic
information about the session – the date, time, and duration of the
session along with problems discussed during the session using the
PST outline.
Number of participants who completed the intervention
Number of participants who did not complete the intervention due
to unplanned discharge or who were referred to specialists
A team of external independent raters expert in the ﬁeld of
delivering Problem-Solving Therapy rated about 10% of the DIL
intervention sessions in order to rate the quality of the sessions
delivered: Quality was assessed through ratings of audio-recordings
and transcripts of audio-recordings, by both peers as well as
psychological treatment experts (supervisors). Sessions were se-
lected by the data manager purposively to ensure that beginning,
middle, and end phases of the intervention were covered. The
Therapy Quality Assessment Form was used to rate the quality of the
session, with feedback provided to the counsellors by both peers and
supervisors. Group supervision meetings took place once weekly. In
Supplementary Table 2, we describe challenges commonly encoun-
tered in the delivery of DIL, together with steps taken to meet these
challenges.
3.14. Nested qualitative study (exit qualitative study)
We plan to conduct in-depth exit interviews with 20 participants but
may increase the number if thematic saturation is not attained. The
sample will be purposively selected and will include representatives
from both the intervention and control arm. We will also select
participants who have beneﬁtted from the study and those who have
experienced an episode of clinical depression or anxiety. A proportion
of participants who have dropped out of the study will also be included
for the interviews. The objective of the interview will be to obtain
feedback on the acceptability and helpfulness of the intervention.
3.15. Data collection and management
Quantitative data were collected for the baseline assessment, the
intervention process and the outcome evaluations (at 3, 6 and 12
months post enrolment). Data were collected electronically using Tablet
computers at the participating sites for the baseline and outcome
evaluations. We used the STAR software designed by Sangath, pre-
viously used in other studies [12,15,17] conducted at Sangath and
found to be extremely feasible and eﬀective. Elderly patients visiting
the primary health centre were approached by members of the research
team and assessed for eligibility. If the patient was eligible, informed
consent was sought for enrolment in the study. Data were then
uploaded to the Sangath server, from which the data manager down-
loaded and stored it in a password -protected computer. Data from the
intervention sessions were recorded on paper and subsequently entered
into the electronic system by the data manager on a weekly basis. Back
up of all the data was maintained in hard disks on a daily basis.
No member of the trial had access to the data except the data
manager. Hard copies of the data were locked in a cupboard, with
access only to the data manager.
3.16. Analysis (descriptive, outcome & qualitative)
Data will be analyzed at the University of Pittsburgh Graduate
School of Public Health, under the supervision of Stewart Anderson,
Ph.D., Professor of Biostatistics. We will examine data descriptively
using cross-tabulation, histograms and tests for normality (with correc-
tive actions, data transformation or nonparametric alternatives as
needed for subsequent analyses).
Primary analyses of the data from this study will be performed using
the principle of intention to treat, that is, all patients randomized will
be included over all of their observed time and will be analyzed
according to the group to which they were randomized regardless of
their eligibility or compliance status. Secondary investigations to
explore the potential eﬀect of interventions in compliant individuals
will employ “per protocol” analyses that may include only fully
compliant individuals. The proportion of individuals who are lost to
follow-up or otherwise have missing endpoints will be assessed over
time using a Kaplan-Meier approach.
The analyses for the outcomes measured longitudinally at several
Table 2
Primary and Secondary outcomes of the DIL trial could add social anxiety disorder as well.
Outcome Data Source End-point
Severity of symptoms GHQ 3, 6, 12 months
Disability levels WHODAS 12 months
Suicidal behaviour PHQ-9 (item-9) and additional questions on suicide thoughts/attempts 3, 6, 12 months
Major depressive episode MINI 6.0 3, 6, 12 months
Panic disorder MINI 6.0 3, 6, 12 months
Generalized anxiety disorder MINI 6.0 3, 6, 12 months
Alcohol abuse/dependence MINI 6.0 3, 6, 12 months
Substance abuse/dependence MINI 6.0 3, 6, 12 months
Cognitive performance HMMSE 12 months
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time points (GHQ, MINI 6.0, modiﬁed PHQ-9) [5,6,16] will seek to
compare trajectories of the outcomes between interventions over the
complete time period of the study. Analyses of other outcomes that are
measured only at the time of entry and at 12 months (HMMSE,
WHODAS [21]) will seek to compare the change of those outcomes
from baseline between intervention groups.
To characterize and compare the trajectories between interventions,
we will employ a mixed model approach using intervention and time,
and adjusting primarily for the stratiﬁcation variables (urban/rural
status, sex and the site of recruitment). Tests of time by intervention
and stratiﬁcation variable by intervention interactions will be em-
ployed. If such interaction terms are signiﬁcant then they will be
appropriately included in the ﬁnal mixed eﬀect models for the
comparison of interventions. Other covariates such as age, gender,
education, history of previous anxiety and depression will also be
explored for potential relationships with outcomes of interest. Tests of
the normality of the outcome variables will be employed and if such
tests indicate lack of normality, then log or square root transformations
will be employed when appropriate. The best ﬁtting models will be
determined by examining individual coeﬃcients for signiﬁcance within
multivariate models and also comparing BIC values between models.
Time variables in the analysis will be derived by subtracting the date of
randomization from the actual date of assessment at each time point.
Because of the growth curve analysis approach that we will use,
missing outcome information, when the proportion of missing data is
small, is not problematic. This is also true if the missingness is
completely at random (MCAR) or at random (MAR) as long as the
missing data mechanism is properly accounted for. Accordingly, we will
employ tests for determining whether or not the missingness is at
random. If appropriate, imputation methods will be considered for
missing data and appropriate sensitivity analyses will be performed.
Marginal signiﬁcance levels of formal tests will be set at α = 0.05.
While we acknowledge that multiple endpoints are being tested, this
trial is a pilot study and hence, we will relax the strict experiment-wise
error rates associated with multiple testing procedures. However, tests
with p-values less than 0.01 will be noted as particularly strong
evidence of diﬀerences between the two arms.
3.17. Ethical considerations
The trial protocol was approved by the Institutional Review Boards
at Goa Medical College, Sangath (an NGO in Goa and the major public
mental health research institute in India), the London School of
Hygiene and Tropical Medicine, and the University of Pittsburgh. In
addition, we obtained approval from the Indian Council for Medical
Research. Written informed consent is mandatory for all enrolments,
and the process of consent was audio-recorded for quality assessments.
In the case of illiterate participants, a signiﬁcant other (SO), ideally a
family member, was involved. In such cases, a witness signature was
obtained from the SO. Care was taken to protect conﬁdentiality and
anonymity of the participant by assigning a unique trial ID to each
participant. The records of all participants were speciﬁed only by the
trial ID. Hard copies of all the data collected were stored in a locked
cabinet with access only to the data manager. Similarly, soft data were
password protected with access rights given only to the data manager.
Whenever a participant developed a depressive or anxiety disorder
during the trial, s/he was referred to attending physicians for further
evaluation and treatment. We developed a suicide risk assessment
protocol (approved by the IRB) specifying steps to be taken in the event
a participant became suicidal during the trial. To date this event has not
occurred (see Fig. 1).
3.18. Trial management
In order to monitor the conduct and progress of the trial, a trial
management committee was formed and held teleconferences every
two weeks. In addition, we formed a Data Safety Monitoring Board
(DSMB) to review the progress of the trial and to review serious adverse
events. The DSMB could make recommendations to view un-blinded
data prior to the completion of the study. The DSMB has met twice
annually through teleconference meetings to review the progress of the
trial, data integrity, and participant safety. Following all ﬁve meetings
of the DSMB, a recommendation to continue the DIL trial without
modiﬁcation of design was made (see Table 3).
4. Discussion
“DIL” is the ﬁrst randomized clinical trial addressing the prevention
of common mental disorders (depression and anxiety) in a low or
middle income country. By implementing a model which uses lay
health counsellors, DIL circumvents the challenge of scarce mental
health resources and allows more rational and eﬃcient use of these
resources, to the potential beneﬁt of a large population of older adults
in primary care settings. DIL builds upon the MANAS trial (“Promoting
Mental Health”), extending the deployment of lay health counsellors
from treating to preventing common mental disorders (depression and
anxiety) in rural and urban primary care clinics. DIL's focus on
preventing common mental disorders in older adults is based upon a
recognition of India's growing population of persons aged 60 and older.
In addition, since the treatment of disorders like depression is only
partially successful in averting years lived with disability, prevention of
depression becomes an important public health priority. Not only is
depression a major contributor to the global burden of illness-related
disability, it also is now recognized as an important risk factor for the
subsequent onset of dementing illnesses and for shortening life ex-
pectancy. Thus, it is plausible to suggest that preventing depression in
older adults may also repay downstream beneﬁts in terms of both
quality and quantity of life. Depression is an important contributor to
care-giver burden; thus its prevention may be a beneﬁt to the wellbeing
of family members, as well as to at-risk older adults.
Table 3
Trial management committees.
Committee Role Members Meeting
frequency
Trial Steering Committee
(TSC)
To monitor all aspects of the conduct and progress of the trial, ensure that the
protocol is adhered to and take appropriate action to safeguard participants and
the quality of the trial itself
Principal Investigator Twice a month
Co-investigators
Project Coordinator
Intervention Facilitator
Research Coordinator
Data Manager
Data Safety Monitoring
Board (DSMB)
To review serious adverse event reports in order to assess whether there are any
safety issues that should be brought to participants' attention or any reasons for
the trial not to continue. It is the only body that makes recommendations to
unblind data and makes further recommendations to the Trial Steering Committee
K S Shaji (Psychiatrist), Six-monthly
Ladson Hinton (Geriatric Psychiatrist),
Sunita Bandewar (Anthropologist with
expertise in research ethics),
Girish Rao (Psychiatrist)
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Randomized clinical trials of indicated depression prevention con-
ducted in high-income countries have generally shown an incidence
rate reduction on the order of 20–25% over varying follow-up intervals
of 1–2 years, in persons living with subsyndromal symptoms. DIL now
lays the groundwork for the extension of prevention science into low
and middle income countries, via a potentially scalable model using lay
health counsellors to reduce the burden of symptoms, improve well-
being and health-related quality of life, and delay or prevent the onset
of major depression, generalized anxiety disorder, and other common
mental illnesses. Further down-stream beneﬁts may also accrue,
including better adherence with co-prescribed medical treatments.
DIL shares several important features with randomized mental
illness prevention trials conducted in high-income countries. Primary
among these shared features is the use of a brief behavioural interven-
tion based in learning theory, namely, Problem Solving Therapy (PST).
PST is eﬀective in the treatment of prevalent mental disorders like
depression; its use in the service of prevention is based upon two
considerations: (1) its behaviourally activating eﬀects, and (2) its
teaching of problem solving strategies that restore active coping and
support a sense of self-eﬃcacy to counteract the “learned helplessness”
at the core of depression. Like preventive interventions conducted in
high-income countries, PST as adapted for use in India is a brief
intervention that entails relatively little face-to-face time with the lay
health counsellor, on the order of 6 h, during the initial 5–7 sessions
and in quarterly booster sessions during the follow up interval.
The adaptation of PST for use in the DIL RCT was based upon
lessons learned during the initial qualitative work and open-case series.
In particular, these lessons addressed three needs: (1) to simplify the
seven steps of traditional PST (“INSPIRE”) into a more easily managed
“package” of three steps (“SAUD”) that could be easily taught via the
use of pictorial ﬂip charts to elders of limited literacy; (2) to incorporate
basic social casework to help elders access needed services; and (3) to
impart basic information about commonly occurring medical comor-
bidities, especially useful and straightforward techniques of self-care. It
is our impression that the modiﬁcation and enrichment of PST
contributed to the high retention rates observed among trial partici-
pants, with less than a 20% dropout rate (comparable to trials
conducted in high-income countries).
In summary, our intervention development research has now
achieved its primary goal of adapting the use of simple behavioural
interventions to prevent common mental disorders in a low- or middle-
income country, for implementation by lay health counsellors, to older
adults with subsyndromal symptoms attending rural and urban primary
care clinics. The adaptation has necessitated the integration of simple
social casework interventions and basic health education in commonly
comorbid medical disorders such as hypertension and diabetes. These
adaptations have been well received by patients and family caregivers
and are seen as responsive to the particular social and medical contexts
in which indicated prevention of common mental disorders can unfold
in a low- or middle-income country having large proportions of older
patients with limited health literacy. Our intervention development
work has demonstrated the feasibility of both enrolling and retaining
at-risk participants (with dropout rates of less than 20%), together with
the safety and acceptability of “indicated” depression prevention.
Finally, it is our contention that DIL should be viewed within the
larger framework of successful, active aging. Thus, DIL is not only about
preventing depression. It also focuses on restoration of a sense of well-
being in elders burdened with emotional distress, and it teaches and
reinforces skills of active coping with the common challenges of old
age.
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